Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial
Article in BMC Medicine (February 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in BMC Medicine (February 2024)
Article in Stem Cell Research & Therapy (December 2023)